Table 2.
Risk factors for tractional retinal detachment*.
| Risk factor | P | CI 95% |
|---|---|---|
| More than 15 years from the diagnosis of diabetes mellitus | .009‡ | 0.10–0.83 |
| More than 13 days from injection to vitrectomy | .0001‡ | 3.4–29 |
| Use of a higher dose (2.5 mg) of bevacizumab | .022‡ | 1.05–7.18 |
| Diabetes Type | .833 | 0.34–2.20 |
| Fibrovascular proliferation | .260 | 0.38–12.15 |
| History of smoking | .408 | 0.11–2.41 |
| History of HTA | .534 | 0.29–1.87 |
| Prior Myocardial Infarction | .10 | 0.088–2.73 |
| Prior Cerebrovascular Accident | .51 | 0.33–14.7 |
| Total Cholesterol | .895 | 0.16–4.53 |
| Triglycerides | .453 | 0.08–9.12 |
| Hemoglobin levels | .796 | 0.07–4.40 |
| Macular Thickness of DME | .123 | 0.33–11.65 |
| Preretinal Hemorrhage | .317 | 0.33–17.5 |
| Vitreous Hemorrhage | .292 | 0.24–1.47 |
| Previous vitrectomy | .632 | 0.49–24.97 |
*DME: Diabetic Macular Edema; TRD: Tractional Retinal Detachment; HTA: Hypertension.
‡Statistically significant.